What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings [Yahoo! Finance]
Orchestra BioMed Holdings, Inc. - Ordinary Shares (OBIO)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2025 revenue is $0.76 million, and the earnings are expected to come in at -$0.42 per share. The full year 2025's revenue is expected to be $3.40 million and the earnings are expected to be -$1.78 per share. More detailed estimate data can be found on the Forecast page Orchestra BioMed Holdings Inc ( NASDAQ:OBIO ) Estimates Trends Warning! GuruFocus has detected 5 Warning Signs with OBIO. Is OBIO fairly valued? Test your thesis with our free DCF calculator. Revenue estimates for Orchestra BioMed Holdings Inc ( NASDAQ:OBIO ) have increased from $3.12 million to $3.40 million for the full year 2025 and from $3.47 million to $3.77 million for 2026 over the past 90 days. Earnings estimates have improved from -$1.99 per share to -$1.78 per share for the full year 2025 and from -$1.75 per share to -$1.54 per share for 2026 over the past 90 days. Orchestra BioMed Holdings Inc ( NASDAQ:OBIO ) Reported History In the previous quarter of 2025-06-30, Orc
Show less
Read more
Impact Snapshot
Event Time:
OBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OBIO alerts
High impacting Orchestra BioMed Holdings, Inc. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
OBIO
News
- Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements [Yahoo! Finance]Yahoo! Finance
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Orchestra BioMed (NASDAQ:OBIO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.MarketBeat
- Orchestra BioMed (NASDAQ:OBIO) had its price target lowered by analysts at Barclays PLC from $12.00 to $11.00. They now have an "overweight" rating on the stock.MarketBeat
OBIO
Sec Filings
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- 11/21/25 - Form 424B3
- OBIO's page on the SEC website